Boswellia

Boswellia serrata is a tree native to India that produces a resin traditionally burned as incense and used in Ayurvedic medicine for inflammatory conditions. The therapeutic compounds are boswellic acids, particularly 3-O-acetyl-11-keto-β-boswellic acid (AKBA), which inhibit 5-lipoxygenase (5-LOX) - a key enzyme in the inflammatory cascade.

Unlike NSAIDs that block COX enzymes, boswellia's unique mechanism targets the 5-LOX pathway, potentially offering anti-inflammatory benefits without the gastrointestinal side effects associated with conventional pain medications. This makes it particularly interesting for long-term use in chronic inflammatory conditions.

Boswellia has a good safety profile with most people tolerating it well. The most common side effects are mild gastrointestinal symptoms including stomach upset, nausea, acid reflux, or diarrhea, typically occurring at higher doses or when taken on an empty stomach. Skin reactions including rash or itching are reported rarely. Unlike NSAIDs, boswellia doesn't appear to cause stomach ulcers or kidney problems with long-term use.

• NSAIDs - May have additive anti-inflammatory effects, potentially increasing side effects • Blood thinners - Theoretical increased bleeding risk due to anti-platelet activity • Immunosuppressive drugs - May interfere with medications that suppress immune function • Anti-inflammatory medications - Could enhance effects of other anti-inflammatory drugs • Diabetes medications - May affect blood sugar levels (limited evidence)

Start with lower doses if taking other anti-inflammatory medications.

Osteoarthritis: 300-400 mg daily of extract standardized to contain 30-65% boswellic acids with at least 10% AKBA, typically divided into 2-3 doses.

General Anti-inflammatory Support: 100-300 mg daily of standardized extract.

Timing: Take with meals to minimize stomach upset. Effects typically develop over 4-8 weeks of consistent use. AKBA content is crucial - avoid products without this standardization as they're likely ineffective.

Quality boswellia extracts range from $18-40 monthly, with price closely tied to AKBA content and extraction quality. Basic boswellia powder or non-standardized extracts cost $12-20 but are unlikely to provide clinical benefits. Pharmaceutical-grade extracts standardized to 20% AKBA or higher cost $25-40 monthly but offer the most reliable effects. The specialized extraction process required to concentrate AKBA makes quality products inherently more expensive than basic herbal supplements.